Clinical evaluation of cimavax EGF in schedule vaccine-chemotherapyvaccine in the treatment of patients with hormone-refractory prostate tumours. Preliminary results

Authors
Category Primary study
JournalVacciMonitor
Year 2010
This article has no abstract
Epistemonikos ID: 1f42fb2bf85802e6b7ee3f9316388e313a91179e
First added on: Feb 07, 2025